Cantitate/Preț
Produs

Radiopharmaceuticals for Therapy

Autor F. F. (Russ) Knapp, Ashutosh Dash
en Limba Engleză Paperback – 31 mar 2018
This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation.  Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy.  In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 60220 lei  38-44 zile
  Springer India – 31 mar 2018 60220 lei  38-44 zile
Hardback (1) 104340 lei  3-5 săpt.
  Springer India – 29 ian 2016 104340 lei  3-5 săpt.

Preț: 60220 lei

Preț vechi: 63390 lei
-5% Nou

Puncte Express: 903

Preț estimativ în valută:
11525 11971$ 9573£

Carte tipărită la comandă

Livrare economică 30 ianuarie-05 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9788132237983
ISBN-10: 8132237986
Pagini: 347
Ilustrații: XXIV, 347 p. 157 illus., 85 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:Softcover reprint of the original 1st ed. 2016
Editura: Springer India
Colecția Springer
Locul publicării:New Delhi, India

Cuprins

Chapter 1-Introduction-Radiopharmaceuticals Play an Important Role in both Diagnostic and Therapeutic Nuclear Medicine.- Chapter 2 – Therapeutic Radionuclides Decay with Particle Emission for Therapeutic Applications.- Chapter 3 - Alpha Radionuclide Therapy.- Chapter 4-Auger Electron-Based Radionuclide Therapy.- Chapter 5-Reactor-Produced Therapeutic Radionuclides.- Chapter 6-Accelerator-Produced Therapeutic Radionuclide.- Chapter 7-Radionuclide Generator Systems Represent Convenient Production Systems to Provide Therapeutic Radionuclides.- Chapter 8-Alpha-Emitting Radionuclide Production.- Chapter 9 - Radioimmunotherapy (RIT).- Chapter 10–Peptides for Receptor Radionuclide Therapy (PRRT).- Chapter 11-Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Hepatic Cancer.- Chapter 12-Therapeutic Radiopharmaceuticals for Bone Pain Palliation.- Chapter 13-Locoregional Radionuclide Therapy for Non-Melanoma Skin Cancer (NMSC).- Chapter 14-Radionuclide Synovectomy – Treatment of Inflammation of the Synovial Joints.- Chapter 15 - Inhibition of Arterial Restenosis following Balloon Angioplasty.- Chapter 16 - Moving Forward – Expected Opportunities for the Development of New Therapeutic Agents Based on Nano Technologies.- Chapter 17. Translation of Radiopharmaceuticals From Bench to Bedside – Regulatory and Manufacturing Issues.
 
 

Recenzii

“Radiopharmaceuticals for Therapy is a well-executed book, divided into 5 parts with the primary focus on the use of radioisotopes for the treatment of disease. … Radiopharmaceuticals for Therapy is a comprehensive volume on radiotherapeutics and unquestionably delivers on its promise to be highly useful to the nuclear medicine professional.” (Dao Le, Journal of Nuclear Medicine, Vol. 58 (9), September, 2017)
“This book … extensively analyzes almost all the aspects related to the development and use of radiopharmaceuticals for therapeutic use. … Their publication is tuned to a multidisciplinary audience ranging from students/residents and practitioners involved in the field, including not only physicians specialized in nuclear medicine … also radiochemists, radiopharmacists, physicists, biologists and others. In addition, it is intended for practitionersand/or students, looking for an upgrade in this charming and ever-expanding field of special cancer therapies.” (Gianluca De Matteis and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, 2017)

Notă biografică

F. F. (Russ) Knapp, Jr., Ph.D. Emeritus Program Manager Corporate Fellow ORNL Medical Radioisotope Program Nuclear Security and Isotope Division Bldg. 4501, MS 6229 Oak Ridge National Laboratory (ORNL) PO Box 2008 1 Bethel Valley Road Oak Ridge, TN 37830-6229

Dr. Ashutosh Dash Head, Isotope Production and Applications Division Professor, Homi Bhabha National Institute Bhabha Atomic Research Centre Mumbai, 400085, India






Textul de pe ultima copertă

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation.  Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT). Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy.  In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.

Caracteristici

First comprehensive discussion of the basic science integrated with descriptions of their clinical applications Provides overview of radioisotope production and processing technologies, key targeting strategies for treatment of cancer and chronic disease processes, and how radiopharmaceuticals are developed, tested and evaluated in clinical trials Combines all aspects of the availability of radioisotopes and their use for radiopharmaceutical development and applications in clinical nuclear medicine